Sensus Healthcare faced a challenging second quarter in 2026, largely influenced by delays in securing financing for equipment orders. Despite a notable decline in revenue and units sold compared to the previous year, the company successfully addressed these issues by securing approvals for the delayed units, which are now slated to contribute to third-quarter earnings. This period also saw Sensus Healthcare strategically shift its commercial focus towards establishing a more diverse customer base and fostering recurring revenue streams, moving beyond its previous reliance on a single major client.
Key financial figures for the second quarter highlighted a revenue of $2.3 million, a significant drop from $7.3 million in Q2 2025, with only 11 units sold compared to 19 in the prior year. The average selling price for SRT-100 units is projected to be around $250,000. Gross margin decreased to 34.8% from 39.7%, and the company reported a net loss of $8.7 million, including a substantial valuation allowance against net deferred tax assets. Operating expenses, however, saw a reduction due to lower compensation and development costs. The company's cash reserves decreased, while inventory levels rose in anticipation of future sales. Management expressed confidence in a stronger second half, projecting sales of 20 or more units per quarter, driven by increasing commercial activity, especially in direct sales and recurring revenue models.
Looking forward, Sensus Healthcare is prioritizing ongoing education for the new CPT codes, accelerating customer adoption, expanding its recurring revenue models, broadening its market reach, and ultimately driving towards sustained profitability. The company's strategic initiatives include targeting larger physician groups and healthcare systems in the U.S., as well as expanding into the Asia-Pacific region, particularly Australia, where there is a high incidence of skin cancer. The Sensus Link software platform is also seeing nearly 100% adoption with new system purchases, further supporting recurring revenue growth. These efforts are expected to solidify the company's market position and drive improved financial performance in the upcoming quarters.
Sensus Healthcare's journey through a challenging quarter demonstrates resilience and a forward-thinking approach. By actively adapting its sales strategies and exploring new markets, the company is building a solid foundation for sustainable growth and long-term success. The commitment to innovation, customer education, and strategic partnerships exemplifies a dedication to not only overcoming current obstacles but also shaping a brighter future in the healthcare technology sector.
